MedPath
NMPA Approval

Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli)

国药准字S20190047

September 6, 2024

Drug Information

双价人乳头瘤病毒疫苗(大肠杆菌)

馨可宁(Cecolin)

注射剂

每瓶/支0.5ml,含重组人乳头瘤病毒16型L1蛋白40μg,重组人乳头瘤病毒18型L1蛋白20μg。

生物制品

September 6, 2024

Company Information

Applicant Company

厦门市海沧区山边洪东路50号一层

Manufacturing Company

福建省厦门市海沧区山边洪东路52号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

双价人乳头瘤病毒疫苗(大肠杆菌) - NMPA 批准文号 | MedPath